APA Alıntı

Richman, J., Ring, A., Dowsett, M., & Sestak, I. (2020). Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer. Breast Cancer Res Treat.

Chicago Stili Alıntı

Richman, Juliet, Alistair Ring, Mitch Dowsett, ve Ivana Sestak. "Clinical Validity of Clinical Treatment Score 5 (CTS5) for Estimating Risk of Late Recurrence in Unselected, Non-trial Patients With Early Oestrogen Receptor-positive Breast Cancer." Breast Cancer Res Treat 2020.

MLA Alıntı

Richman, Juliet, Alistair Ring, Mitch Dowsett, ve Ivana Sestak. "Clinical Validity of Clinical Treatment Score 5 (CTS5) for Estimating Risk of Late Recurrence in Unselected, Non-trial Patients With Early Oestrogen Receptor-positive Breast Cancer." Breast Cancer Res Treat 2020.